* Requires Referral For New Patients *
Publications
Poster Presentation
“Effect of Radioactive Iodine Treatment on Grave’s Ophthalmopathy,” American Thyroid Association meeting, Colorado Springs, Colorado, 1997
Research- Phase II-IV Studies
Short Term, Multicenter, Randomized, Open-Label, Parallel-Group Study Assessing the Pulmonary Effects of Chronically Dosed Inhaled or Subcutaneous Insulin Therapy. Pfizer A2171027
Efficacy and Safety of Exubera (inhaled insulin) Compared with Subcutaneous Human Insulin Therapy in Adult Subject with Type-2 Diabetes Mellitus:
A Two -year, Outpatient, Open-Label, Parallel-Group Comparative Trial. Pfizer A2171029
A Multi-national, Randomized, Double-blind, Placebo-Controlled, Force Titration, 2×2 Factorial Design Study of the Efficacy and Safety of Long Term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects with Impaired Glucose Tolerance (IGT). Novartis CDJN608B2302
Publication
Effect of 131 Iodine Therapy on the Course of Graves’ Ophthalmopathy:
A Quantitative Analysis of Extraocular Muscle Volumes Using Orbital Magnetic Resonance Imaging, Thyroid: 2001.
Speaker’s Bureau
AbbVie, Astra-Zeneca, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk Sanofi.
Biography
Dr. Rajiv Dattatreya, originally from India, obtained a medical degree from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India in 1986. He completed an Internal Medicine residency program at Albert Einstein College of Medicine, New York. Subsequently, he completed his Endocrinology fellowship at Cleveland Clinic, Ohio.
Dr. Dattatreya is board certified in Endocrinology, Diabetes, and Metabolism. He specializes in disorders of the Endocrine system, including Thyroid, Diabetes and metabolism, and osteoporosis. He is a Fellow of the American Association of Clinical Endocrinologists (AACE)